EDGAR Filing Documents for 0001104659-20-071096

Form 8-K - Current report:

SEC Accession No. 0001104659-20-071096

Filing Date

2020-06-09

Accepted

2020-06-09 07:37:37

Documents

Period of Report

2020-06-08

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2022106d1_8k.htm	8-K	36902
2	EXHIBIT 10.1	tm2022106d1_ex10-1.htm	EX-10.1	320620
3	EXHIBIT 10.2	tm2022106d1_ex10-2.htm	EX-10.2	107104
4	EXHIBIT 10.3	tm2022106d1_ex10-3.htm	EX-10.3	52270
5	EXHIBIT 99.1	tm2022106d1_ex99-1.htm	EX-99.1	16365
6	GRAPHIC	tm2022106d1_ex99-1img001.jpg	GRAPHIC	3813
	Complete submission text file	0001104659-20-071096.txt		540201

Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109

Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774

ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)